We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bidtimes | BDT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.75 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.75 | 1.75 |
| Top Posts |
|---|
Posted at 22/3/2011 14:02 by lbo Maybe they found a deal and something about to list via BDT?"the Company continued to focus on identifying and assessing investment opportunities in the energy sector, particularly the alternative energy sector. The Company is continuing to assess an opportunity in the clean energy sector which was highlighted in the Company's last annual report, as the Directors believe that considerable opportunities with the potential to create shareholder value exist within this industry" |
Posted at 01/10/2010 20:48 by xlairways Anyone else getting cold calls from someone in india about there BDT holding? |
Posted at 24/7/2007 14:53 by latestarter the adminstrators of MRD held a sealed bid for the stake they held in BDT |
Posted at 01/12/2006 15:09 by lbo I presume you mean Meriden not Merde???. Its others now who will pull the strings here. Reverse takeovers should be on the way for BDT and SGY.Out with old and in with the new! (Another SR Pharma (SPA) would be ideal here) LONDON (AFX) - Investment company SRS Technology Group PLC said it is seeking new business opportunities and plans an acquisition preferably in the form of a reverse takeover. The company said it is searching for an acquisition, preferably through reverse takeover, in sectors such as healthcare, natural resources, telecoms, financial or environmental |
Posted at 17/11/2006 09:21 by lbo I think you will find that Blue chip is ok and growing revenues. The reason for the EBITDA fall may be explained by preopening expenses for the opening of new venues like the Blue Chip-Walsall pub-style casino and the Queens casino in Warley. Also the UK gambling laws have if anything increased the valuation on operators like blue chip. (ps I also forgot to mention the 150k loan to the Blue Chip director above)And how has RS kept BDT a float? I am sure he is not paying over the odds for the properties and going on the previous disposals and the rent roll on the three he is buying I am sure they would have fetched a bit more in time. But things need to move faster now and everything needs to be in order as its the Reverse take over and the buyer of the Dawney Day stake that will make for interesting times around the corner. Many interested in parties looking for a cheap way for an AIM listing at the moment. Just look at SR Pharma (SPA) and you can see how shareholders can gain from the right reverse take over |
Posted at 17/11/2006 08:58 by latestarter if you read the MRD accounts you will see RS had personally guranteed the purchase of the BDT stake and would make good any loss on its subsequent sale, ergo did he really have a choice but to keep BDT afloat in the short term? |
Posted at 16/11/2006 20:33 by lbo FYIThe AIM listing alone is worth 500k and its the reverse takeover that will be interesting especially with Dawney Day owning 18% of BDT already. Who ever does a deal with them controls this. Also "The company's borrowings, which have now been reduced to £563,530" and "realising the remaining properties for gross proceeds amounting to £788,000" Leaves circa £150k in cash And then you have the Blue Chip Casino stake which is in at £75k but "The Board is,however, confident of the potential of the investment in Blue Chip Casinos Plc, but has adopted a prudent approach and continued to value this investment at its original cost" and FYI The blue chip casinos stake was worth circa 375k at the last valuation when Isle of Capri bought its stake |
Posted at 30/8/2006 09:53 by shawzie Final results well overdue - for such a small operation, results could bepublished by end of March. I suspect that the Directors wait six months to see how their other interest are turning out, or if good news can be issued to the market, before finalising BDT Report and Financial Statement. |
Posted at 12/6/2006 11:00 by shawzie I have been looking at the ADVFN Financial data for BDT and note that the following is shown :-Market Capital £1.15M Shares in Issue 40M NAV/Share 1.86p I have asked ADVFN to check and correct such figures if necessary,as I thought that Shares on issue stood at 17,373,523 - can anyone confirm? |
Posted at 07/6/2006 19:53 by shawzie lboCalled up share capital 868,676 Share premium 714,948 Revaluation reserve 123,856 Profit and loss account (1,127,892) ------------- Equity shareholders' funds 579,588 ------------- Bidtimes - The Board of Directors, by the decisions taken, has lost over £1M of shareholders funds. Innobox - The Board of Directors, by the decisions taken, has lost over £1M of shareholders funds. Meriden - now loss making. The common factor in all of these AIM listed companies is Russell Stevens. I quote from the last Annual Report and Financial Statement for Bidtimes - THE DIRECTORS' OPINION OF THE MARKET VALUE OF THIS INVESTMENT (Blue Chip) BASED ON THE CURRENT PERFORMANCE OF THE COMPANY 28/2/05 IS EQUAL TO ITS COST OF £73,867 How can this investment be worth around £375,000 If it was, then the Directors would surely make a note in the accounts stating that although for accounting purposes it is shown at cost, in their opinion it was worth £375,000. As far as Bidtimes is concerned the investment in SRS is bad judgement. The investment in Innobox should have been sold some time ago as the value of Innobox is sliding down the pan and of course two properties have been sold at a loss of £4,500 and £7,500 not counting the disposal costs. Surely you jest when you quote "INO to be used if needs be to fund the next move for BDT" I am more interested in what Russell Stevens does, rather than what he is reputed to say. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
